Stock Events

Stock Events

Journey Medical 

$4.72
10
+$0.02+0.53% Today

Statistics

Day High
5
Day Low
4.68
52W High
9.56
52W Low
4.31
Volume
140,071
Avg. Volume
190,631
Mkt Cap
99.66M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

19MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.24
-0.12
-0.01
0.1
Expected EPS
-0.0775
Actual EPS
N/A

Financials

-26.14%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
112.27MRevenue
-29.34MNet Income

Analyst Ratings

$13.00Average Price Target
The highest estimate is 13.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DERM. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its Janssen Pharmaceuticals segment, develops treatments for various dermatological conditions, directly competing with Journey Medical.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. provides medications and vaccines for various conditions, including dermatological diseases, competing with Journey Medical's offerings.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. has a diverse range of healthcare products, including treatments for skin conditions that compete with Journey Medical's dermatology products.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline plc offers a variety of prescription medicines and vaccines, some of which are for dermatological conditions, making it a competitor.
Novartis
NVS
Mkt Cap237.61B
Novartis AG, through its Sandoz division, offers generic and biosimilar dermatology products, competing in the same market as Journey Medical.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc., with its acquisition of Allergan, has a strong dermatology portfolio that competes with Journey Medical's dermatological treatments.
AMGEN
AMGN
Mkt Cap160.66B
Amgen Inc. develops biologic medicines for various conditions, including psoriasis, a key area of competition with Journey Medical.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb offers treatments for a range of diseases, including skin conditions, competing with Journey Medical's dermatology focus.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals, Inc. is known for its innovative treatments in dermatology, including eczema, directly competing with Journey Medical.

About

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
Show more...
CEO
Dr. Lindsay Allan Rosenwald M.D.
Employees
41
Country
US
ISIN
US48115J1097

Listings

BOATS
BOATS
DERM.BOATS
XNAS
US
DERM

0 Comments

Share your thoughts

FAQ

What is Journey Medical stock price today?▼
The current price of DERM is $4.72 USD — it has increased by +0.53% in the past 24 hours. Watch Journey Medical stock price performance more closely on the chart.
What is Journey Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Journey Medical stocks are traded under the ticker DERM.
Is Journey Medical stock price growing?▼
DERM stock has fallen by -30.75% compared to the previous week, the month change is a -42.11% fall, over the last year Journey Medical has showed a -20.77% decrease.
What is Journey Medical market cap?▼
Today Journey Medical has the market capitalization of 99.66M
When is the next Journey Medical earnings date?▼
Journey Medical is going to release the next earnings report on May 19, 2026.
What were Journey Medical earnings last quarter?▼
DERM earnings for the last quarter are -0.04 USD per share, whereas the estimation was -0.05 USD resulting in a +23.81% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Journey Medical revenue for the last year?▼
Journey Medical revenue for the last year amounts to 112.27M USD.
What is Journey Medical net income for the last year?▼
DERM net income for the last year is -29.34M USD.
How many employees does Journey Medical have?▼
As of April 01, 2026, the company has 41 employees.
In which sector is Journey Medical located?▼
Journey Medical operates in the Health Care sector.
When did Journey Medical complete a stock split?▼
Journey Medical has not had any recent stock splits.
Where is Journey Medical headquartered?▼
Journey Medical is headquartered in Scottsdale, US.